n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Absence Status in 2 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tse, K | 1 |
| Hammond, D | 1 |
| Simpson, D | 1 |
| Beynon, RJ | 1 |
| Beamer, E | 1 |
| Tymianski, M | 1 |
| Salter, MW | 1 |
| Sills, GJ | 1 |
| Thippeswamy, T | 2 |
| Puttachary, S | 1 |
| Sharma, S | 1 |
| Verma, S | 1 |
| Yang, Y | 1 |
| Putra, M | 1 |
| Thippeswamy, A | 1 |
| Luo, D | 1 |
2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Absence Status
| Article | Year |
|---|---|
The impact of postsynaptic density 95 blocking peptide (Tat-NR2B9c) and an iNOS inhibitor (1400W) on proteomic profile of the hippocampus in C57BL/6J mouse model of kainate-induced epileptogenesis.
Topics: Amidines; Animals; Anticonvulsants; Benzylamines; Epilepsy; Hippocampus; Kainic Acid; Male; Mice, In | 2019 |
1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Male; | 2016 |